Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 117

Results For "RMAT"

1287 News Found

FICCI annual healthcare conference from Oct. 20-22nd 2021
Events | October 14, 2021

FICCI annual healthcare conference from Oct. 20-22nd 2021

This is a virtual event and the theme is `Transforming Healthcare beyond Covid’


PCI Pharma Services acquires LSNE for its CDMO business
News | October 13, 2021

PCI Pharma Services acquires LSNE for its CDMO business

Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle


SecureKloud to list subsidiary Healthcare Triangle on Nasdaq
News | October 13, 2021

SecureKloud to list subsidiary Healthcare Triangle on Nasdaq

The company plans to raise US $ 15 million


Lonza to expand development services for mammalian products in Singapore
Biotech | October 13, 2021

Lonza to expand development services for mammalian products in Singapore

This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites


HCL expands its partnership with Google Cloud to focus on healthcare and life sciences
Digitisation | October 12, 2021

HCL expands its partnership with Google Cloud to focus on healthcare and life sciences

HCL will establish a joint centre of excellence (CoE) for Google Cloud with industry subject matter experts and Google Cloud-certified ideapreneurs


Algorithm to calculate number of years one lives with good health
Healthcare | October 12, 2021

Algorithm to calculate number of years one lives with good health

In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks


Covaxin for kids gets nod, final approval awaited
Drug Approval | October 12, 2021

Covaxin for kids gets nod, final approval awaited

The two doses of Covaxin are likely to be administered to children with a gap of 28 days


Intas launches the world's first SB-100mg Itraconazole
Drug Approval | October 12, 2021

Intas launches the world's first SB-100mg Itraconazole

Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage and antacid consumption


Boehringer Ingelheim launches University of Medicine Excellence
News | October 12, 2021

Boehringer Ingelheim launches University of Medicine Excellence

Harvard Medical School will deliver the first customized program, ‘Accelerate’, to create the next generation of leading experts in clinical development and medical affairs


Sai Life Sciences presents its midterm report
News | October 11, 2021

Sai Life Sciences presents its midterm report

The company has enabled a transformation across three core areas with an investment target of US $ 150 million